Strain identifier

BacDive ID: 14747

Type strain: No

Species: Streptococcus pneumoniae

Culture col. no.: DSM 14377, ATCC 6303, CCUG 33062, CIP 104225

Strain history: CIP <- 1994, ATCC <- B.E. Eddy, Diplococcus pneumoniae

NCBI tax ID(s): 1313 (species)

« Browse strain by BacDive ID »

expand / minimize allblue arrow down

Exclude non-curated data/information
Special Collections blue arrow down

Streptococcus pneumoniae DSM 14377 is a microaerophile, Gram-positive human pathogen of the family Streptococcaceae.

  1. Gram-positive
  2. human pathogen
  3. microaerophile
  4. 16S sequence
  5. Bacteria
  6. genome sequence
  • Availability in culture collections External linksarrow_down
    • [Ref.: #5327] Culture collection no. DSM 14377, ATCC 6303, CCUG 33062, CIP 104225
    [Ref.: #83864] SI-ID 307565 *
    Literature: Only first 10 entries are displayed. Click here to see all.Click here to see only first 10 entries.
    arrow to sort Titlearrow to sort Authorsarrow to sort Journalarrow to sort DOIarrow to sort Yeararrow to sort
    Pathogenicity Evaluation of protective immunity responses against pneumococcal PhtD and its C-terminal in combination with outer-membrane vesicles as adjuvants. Malekan M, Siadat SD, Aghasadeghi M, Shahrokhi N, Afrough P, Behrouzi A, Ahmadi K, Mousavi SF J Med Microbiol 10.1099/jmm.0.001103 2020 *
    Pathogenicity A novel ketolide, RBx 14255, with activity against multidrug-resistant Streptococcus pneumoniae. Raj VS, Barman TK, Kalia V, Purnapatre K, Dube S, G R, Bhateja P, Mathur T, Chaira T, Upadhyay DJ, Surase YB, Venkataramanan R, Chakrabarti A, Das B, Bhatnagar PK Antimicrob Agents Chemother 10.1128/AAC.01589-13 2014 *
    Metabolism Intranasal vaccination with chitosan-DNA nanoparticles expressing pneumococcal surface antigen a protects mice against nasopharyngeal colonization by Streptococcus pneumoniae. Xu J, Dai W, Wang Z, Chen B, Li Z, Fan X Clin Vaccine Immunol 10.1128/CVI.00263-10 2010 *
    Pathogenicity Comparison of the pulmonary response against lethal and non-lethal intranasal challenges with two different pneumococcal strains. Ferreira DM, Moreno AT, Cianciarullo AM, Ho PL, Oliveira ML, Miyaji EN Microb Pathog 10.1016/j.micpath.2009.05.005 2009 *
    Genetics Characterization of protective mucosal and systemic immune responses elicited by pneumococcal surface protein PspA and PspC nasal vaccines against a respiratory pneumococcal challenge in mice. Ferreira DM, Darrieux M, Silva DA, Leite LC, Ferreira JM Jr, Ho PL, Miyaji EN, Oliveira ML Clin Vaccine Immunol 10.1128/CVI.00395-08 2009 *
    Enzymology Novel biaryl oxazolidinones: in vitro and in vivo activities with pharmacokinetics in an animal model. Barman TK, Pandya M, Mathur T, Bhadauriya T, Rao M, Khan S, Singhal S, Bhateja P, Sood R, Malhotra S, Das B, Paliwal J, Bhatnagar PK, Upadhyay DJ Int J Antimicrob Agents 10.1016/j.ijantimicag.2008.08.025 2008 *
    Metabolism Effect of protein binding on the pharmacological activity of highly bound antibiotics. Schmidt S, Rock K, Sahre M, Burkhardt O, Brunner M, Lobmeyer MT, Derendorf H Antimicrob Agents Chemother 10.1128/AAC.00427-08 2008 *
    Pathogenicity [Streptococcus pneumoniae growth based on drug resistance genotype]. Miyashita K Kansenshogaku Zasshi 10.11150/kansenshogakuzasshi1970.82.292 2008 *
    Pathogenicity Resistance to both complement activation and phagocytosis in type 3 pneumococci is mediated by the binding of complement regulatory protein factor H. Neeleman C, Geelen SP, Aerts PC, Daha MR, Mollnes TE, Roord JJ, Posthuma G, van Dijk H, Fleer A Infect Immun 10.1128/IAI.67.9.4517-4524.1999 1999 *
    Enzymology Separation and isolation of viable bacteria by capillary zone electrophoresis. Ebersole RC, McCormick RM Biotechnology (N Y) 10.1038/nbt1193-1278 1993 *

Change proposal

You found an error in BacDive? Please tell us about it!

Note that changes will be reviewed and judged. If your changes are legitimate, changes will occur within the next BacDive update. Only proposed changes supported by the according reference will be reviewed. The BacDive team reserves the right to reject proposed changes.

Field you want to change:


CAPTCHAReload captcha

Change proposal

Successfully sent